We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
T-Mobile-Sprint, Pepsi CEO Departs, Jamie Dimon's Latest Wisdom, & More | Free Lunch
Read MoreHide Full Article
On today’s episode of Free Lunch, Associate Stock Strategist Ryan McQueeney highlights today’s trending stories, including the departure of PepsiCo’s CEO, Jamie Dimon’s latest public wisdom, and Bluebird Bio’s new partnership. Later, he recaps recent developments in the T-Mobile-Sprint merger and previews what the combined company might look like.
Free Lunch is the newest show from Zacks Investment Research. It is streamed live, four times per week, and features breaking news and analysis from Zacks strategists. Free Lunch is available on YouTube, Facebook Live, Twitter, Ustream, and more.
This morning’s top story was the surprise announcement that longtime PepsiCo (PEP - Free Report) CEO Indra Nooyi is planning to leave the company’s top position in early October. The widely-praised executive has grown PepsiCo’s sales by 80% in her 12 years at its helm, and her departure leaves just 24 women in charge of Fortune 500 companies.
Ryan reflects on Nooyi’s legacy in the business world at the beginning of the show.
Next, he discusses comments made over the weekend by JPMorgan (JPM - Free Report) chief Jamie Dimon. The bank industry titan is certainly no stranger to public commentary, but it is not always that investors get such a candid perspective on today’s market from Dimon. Make sure to check out the show to hear what he had to say about U.S. Treasury yields and bitcoin!
Later, Ryan discusses the new partnership between Bluebird Bio (BLUE - Free Report) and Regeneron Pharmaceuticals (REGN - Free Report) . The two companies inked a five-year deal which will include a collaborative effort to develop new cell therapies for the treatment of cancer. Regeneron will also invest $100 million in Bluebird shares as a part of the deal.
On the second half of the show, Ryan takes a look at the latest development in the ongoing T-Mobile (TMUS - Free Report) and Sprint (S - Free Report) merger saga.
According to a source cited by the New York Post, US regulators believe three national 5G wireless providers are needed to ensure robust competition. That should spell good news for T-Mobile and Sprint, who argued that they would need to merge in order to launch 5G networks.
With this in mind, Ryan discusses the 5G revolution, how a combined T-Mobile-Sprint might look, and what investors might need to be worried about. Make sure to check out the show to hear more!
Looking for Stocks with Skyrocketing Upside?
Zacks has just released a Special Report on the booming investment opportunities of legal marijuana.
Ignited by new referendums and legislation, this industry is expected to blast from an already robust $6.7 billion to $20.2 billion in 2021. Early investors stand to make a killing, but you have to be ready to act and know just where to look.
Image: Bigstock
T-Mobile-Sprint, Pepsi CEO Departs, Jamie Dimon's Latest Wisdom, & More | Free Lunch
On today’s episode of Free Lunch, Associate Stock Strategist Ryan McQueeney highlights today’s trending stories, including the departure of PepsiCo’s CEO, Jamie Dimon’s latest public wisdom, and Bluebird Bio’s new partnership. Later, he recaps recent developments in the T-Mobile-Sprint merger and previews what the combined company might look like.
Want more video content from Zacks? Subscribe to Zacks Investment News now!
Free Lunch is the newest show from Zacks Investment Research. It is streamed live, four times per week, and features breaking news and analysis from Zacks strategists. Free Lunch is available on YouTube, Facebook Live, Twitter, Ustream, and more.
This morning’s top story was the surprise announcement that longtime PepsiCo (PEP - Free Report) CEO Indra Nooyi is planning to leave the company’s top position in early October. The widely-praised executive has grown PepsiCo’s sales by 80% in her 12 years at its helm, and her departure leaves just 24 women in charge of Fortune 500 companies.
Ryan reflects on Nooyi’s legacy in the business world at the beginning of the show.
Next, he discusses comments made over the weekend by JPMorgan (JPM - Free Report) chief Jamie Dimon. The bank industry titan is certainly no stranger to public commentary, but it is not always that investors get such a candid perspective on today’s market from Dimon. Make sure to check out the show to hear what he had to say about U.S. Treasury yields and bitcoin!
Later, Ryan discusses the new partnership between Bluebird Bio (BLUE - Free Report) and Regeneron Pharmaceuticals (REGN - Free Report) . The two companies inked a five-year deal which will include a collaborative effort to develop new cell therapies for the treatment of cancer. Regeneron will also invest $100 million in Bluebird shares as a part of the deal.
On the second half of the show, Ryan takes a look at the latest development in the ongoing T-Mobile (TMUS - Free Report) and Sprint (S - Free Report) merger saga.
According to a source cited by the New York Post, US regulators believe three national 5G wireless providers are needed to ensure robust competition. That should spell good news for T-Mobile and Sprint, who argued that they would need to merge in order to launch 5G networks.
With this in mind, Ryan discusses the 5G revolution, how a combined T-Mobile-Sprint might look, and what investors might need to be worried about. Make sure to check out the show to hear more!
Looking for Stocks with Skyrocketing Upside?
Zacks has just released a Special Report on the booming investment opportunities of legal marijuana.
Ignited by new referendums and legislation, this industry is expected to blast from an already robust $6.7 billion to $20.2 billion in 2021. Early investors stand to make a killing, but you have to be ready to act and know just where to look.
See the pot trades we're targeting>>